Premium
Measuring the serum level of retinol‐binding protein can enhance the treatment of recalcitrant warts
Author(s) -
Khalid Hesham N.,
Abd El Gayed Eman M.,
Dawoud Rasha A.,
Bazid Heba A. S.
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13683
Subject(s) - pathogenesis , plantar warts , cryotherapy , medicine , retinol binding protein , retinol , biomarker , keratolytic , gastroenterology , dermatology , vitamin , endocrinology , surgery , biology , biochemistry
Background Warts are common benign (60%‐65%) self‐limited tumors of the epidermis caused by human papillomaviruses (HPVs). However, some warts fail to resolve despite of different treatments and become recalcitrant. Vitamin A has antiproliferative and antikeratinizing properties by which the disruption of HPV replication can be occurred. Concentrations of retinol‐binding protein (RBP) and retinol in the circulation highly correlate with each others. Aim To assess the serum level of RBP in patients with resistant warts to evaluate the possible role of retinol in the disease pathogenesis. Patients This case‐control study included 30 patients with resistant cutaneous warts (defined as failure of cure after conventional treatment as 12 weeks of salicylic acid application, 4 or more cycles of cryotherapy or electrocautery and/or other physical treatment modalities) and 30 age‐ and sex‐matched healthy controls. RBP level in the serum was measured by ELISA. Results There was a significant difference between cases and controls regarding the level of serum RBP ( P = .001). However, serum RBP level did not differ significantly regarding sociodemographic or clinical data ( P > .05 each). RBP is a good biomarker for significant early detection and discrimination between cases and controls ( P = .001) at a cutoff point < 563.3 mg/l with sensitivity (93%) and specificity (80%). Conclusion Low serum RBP level in our studied patients may suggest an important role of retinol in the resistant warts pathogenesis. Thus measuring serum RBP will help to identify patients who are going to have resistant warts in the future.